Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration

被引：0
|
作者：
Nathalie Massamba
Ali Dirani
Nathalie Butel
Christine Fardeau
Bahram Bodaghi
April Ingram
Phuc Lehoang
机构：
[1] Pitié salpetrière Hospital,Department of Ophthalmology
[2] UPMC,Department of Ophthalmology
[3] University of Lausanne,Fondation Asile des Aveugles (Foundation Asylum for the Blind)
[4] Jules Gonin Eye Hospital,Department of Ophthalmology
[5] University Paris VI GH Pitié Salpétrière,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2017年 / 255卷
关键词：
Aflibercept; Outer retinal tubulations; Anti-VEGF; Exudative AMD; SD-OCT; Ranibizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：61 / 67
页数：6
相关论文
共 50 条
  • [11] Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability
    Nomura, Yoko
    Yanagi, Yasuo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2015, 59 (04) : 261 - 265
  • [12] Letter to the Editor: Outer Retinal Tubulations and Age-Related Macular Degeneration
    Chin, Eric K.
    Almeida, David R. P.
    Grant, Lorna W.
    Niles, Philip I.
    Folk, James C.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (06): : 604 - 605
  • [13] Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
    Koike, Naoko
    Otsuji, Tsuyoshi
    Tsumura, Akiko
    Miki, Katsuaki
    Sakai, Yukio
    Nishimura, Tetsuya
    Takahashi, Kanji
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1247 - 1251
  • [14] Comparison of Intravitreal Aflibercept with Bevacizumab and Ranibizumab for the Treatment of Wet Age-related Macular Degeneration
    Shaikh, Adeel
    Miller, Daniel
    Petersen, Michael
    Foster, Robert
    Riemann, Christopher
    Sisk, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [15] TOPICAL BROMFENAC AS AN ADJUNCTIVE TREATMENT WITH INTRAVITREAL RANIBIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Gomi, Fumi
    Sawa, Miki
    Tsujikawa, Motokazu
    Nishida, Kohji
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (09): : 1804 - 1810
  • [16] Intravitreal Ranibizumab in the Treatment of Predominantly Hemorrhagic Lesions in Exudative Age-Related Macular Degeneration
    Konstantinidis, L.
    Mantel, I.
    Zografos, L.
    Ambresin, A.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2011, 228 (04) : 288 - 292
  • [17] Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life
    Cazet-Supervielle, Agathe
    Gozlan, Julien
    Cabasson, Severin
    Boissonnot, Michele
    Manic, Helene
    Leveziel, Nicolas
    OPHTHALMOLOGICA, 2015, 234 (01) : 26 - 32
  • [18] Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
    Bakall, Benjamin
    Folk, James C.
    Boldt, H. Culver
    Sohn, Elliott H.
    Stone, Edwin M.
    Russell, Stephen R.
    Mahajan, Vinit B.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 156 (01) : 15 - 22
  • [19] Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
    Hamid, Mohamed A.
    Abdelfattah, Nizar S.
    Salamzadeh, Jamshid
    Abdelaziz, Sahar T. A.
    Sabry, Ahmed M.
    Mourad, Khaled M.
    Shehab, Azza A.
    Kuppermann, Baruch D.
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
  • [20] Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
    Mohamed A. Hamid
    Nizar S. Abdelfattah
    Jamshid Salamzadeh
    Sahar T. A. Abdelaziz
    Ahmed M. Sabry
    Khaled M. Mourad
    Azza A. Shehab
    Baruch D. Kuppermann
    International Journal of Retina and Vitreous, 7
12345